Literature DB >> 20890387

Role of Magnetic Resonance in Understanding the Pathogenesis of Hepatic Encephalopathy.

A Huda1, R K Gupta, N Rajakumar, M A Thomas.   

Abstract

A spectrum of neuropsychiatric abnormalities caused by portosystemic venous shunting occurs in hepatic encephalopathy (HE) patients with or without liver dysfunction. It is not completely clear how the astrocyte swelling leads to glial-neuronal dysfunction, and how the symptoms are manifested in HE. A major goal of this work is to review the current status of information available from the existing magnetic resonance (MR) modalities including MR imaging (MRI) and MR Spectroscopy (MRS) as well as other modalities in the understanding the pathogenesis of HE. First, we discuss briefly neuron-histopathology, neurotoxins, neuropsychological and neurophysiological tests. A short review on the progress with single-photon emission computed tomography (SPECT) and positron emission tomography (PET) is then presented. In the remaining part of the manuscript, the following topics pertinent to understanding the pathogenesis of HE are discussed: MRI, diffusion tensor imaging (DTI), one-dimensional MRS based single- and multi-voxel based spectroscopic imaging techniques and two-dimensional MRS.

Entities:  

Year:  2008        PMID: 20890387      PMCID: PMC2947384          DOI: 10.4137/mri.s973

Source DB:  PubMed          Journal:  Magn Reson Insights        ISSN: 1178-623X


  84 in total

1.  Critical flicker frequency for quantification of low-grade hepatic encephalopathy.

Authors:  Gerald Kircheis; Matthias Wettstein; Lars Timmermann; Alfons Schnitzler; Dieter Häussinger
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

Review 2.  MR imaging findings in hepatic encephalopathy.

Authors:  A Rovira; J Alonso; J Córdoba
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

3.  Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy.

Authors:  Ryosuke Sugimoto; Motoh Iwasa; Masayuki Maeda; Naohito Urawa; Hideaki Tanaka; Naoki Fujita; Yoshinao Kobayashi; Kan Takeda; Masahiko Kaito; Yoshiyuki Takei
Journal:  Am J Gastroenterol       Date:  2008-05-28       Impact factor: 10.864

4.  Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy.

Authors:  R Kreis; N Farrow; B D Ross
Journal:  Lancet       Date:  1990-09-08       Impact factor: 79.321

5.  Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability.

Authors:  A Watanabe; T Tuchida; Y Yata; Y Kuwabara
Journal:  Metab Brain Dis       Date:  1995-09       Impact factor: 3.584

6.  The contribution of endogenous benzodiazepine receptor ligands to the pathogenesis of hepatic encephalopathy.

Authors:  A S Basile
Journal:  Synapse       Date:  1991-02       Impact factor: 2.562

7.  Chronic acquired hepatic failure: MR imaging of the brain at 1.5 T.

Authors:  J A Brunberg; E Kanal; W Hirsch; D H Van Thiel
Journal:  AJNR Am J Neuroradiol       Date:  1991 Sep-Oct       Impact factor: 3.825

8.  Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.

Authors:  Sona Saksena; Vijan Rai; Vivek Anand Saraswat; Ramkishore Singh Rathore; Ankur Purwar; Manoj Kumar; M Albert Thomas; Rakesh Kumar Gupta
Journal:  J Gastroenterol Hepatol       Date:  2007-10-09       Impact factor: 4.029

9.  Ouabain-sensitive choline transport system in capillaries isolated from bovine brain.

Authors:  E Galea; C Estrada
Journal:  J Neurochem       Date:  1992-09       Impact factor: 5.372

10.  Manganese and chronic hepatic encephalopathy.

Authors:  D Krieger; S Krieger; O Jansen; P Gass; L Theilmann; H Lichtnecker
Journal:  Lancet       Date:  1995-07-29       Impact factor: 79.321

View more
  2 in total

1.  Abnormal baseline brain activity in patients with HBV-related cirrhosis without overt hepatic encephalopathy revealed by resting-state functional MRI.

Authors:  Xiao-Fei Lv; Min Ye; Lu-Jun Han; Xue-Lin Zhang; Pei-Qiang Cai; Gui-Hua Jiang; Ying-Wei Qiu; Shi-Jun Qiu; Yao-Pan Wu; Kai Liu; Zhen-Yin Liu; Pei-Hong Wu; Chuan-Miao Xie
Journal:  Metab Brain Dis       Date:  2013-07-09       Impact factor: 3.584

2.  A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation.

Authors:  Rodrigo C Surjan; Elizabeth S Dos Santos; Tiago Basseres; Fabio F Makdissi; Marcel A Machado
Journal:  Am J Case Rep       Date:  2017-03-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.